http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2007006319-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d55b44219a84c850812a4488def924
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-12
filingDate 2005-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d65481b2b52991e37fe0068e017ebd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06e2967d4faee6442b299591b5669ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_488fdca4ee1a88aa0be5b086e80e755d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc4d2f80b696eb384f3644fb009901d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dad24b7a6d80a379ced3bab86e74693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c52a43d0061e074fba121c4e3fde18f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e132a02728bd95e51b0e0b1bfc8a59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_162591f5e6740d0028249b4c9da94182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1188cc9788d39a38590f2f437693c222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2005d45b0a9b2ed6e3fadeec3d2e418
publicationDate 2007-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2007006319-A
titleOfInvention DERIVATIVES OF ANTIBIOTIC GLICOPEPTIC MONOMERS.
abstract Novel glycopeptide antibiotic derivatives; these derivatives are represented by the formula (aglycone part of the antibiotic derivative of glycopeptides) - (Sac-NH) -RA [wherein (the aglycone part of the antibiotic derivative of glycopeptide) is the part formed by removing the sugar part from a known antibiotic derivative of glycopeptide; the part (Sac-NH) is an amino sugar part or a sugar chain part containing an amino sugar; and RA represents, for example, the formula X1-Ar1-XY-Ar2 (where X1, X2, and X3 each represents 1) an individual bond or 2) a heteroatom or a group containing a heteroatom selected from the group consisting of -N =, = N-, NR1-, -O-, etc .; And represents -NR2CO- or -CONR2 - (where R2 represents hydrogen or lower alkyl), etc.)], these derivatives have antibacterial activity against vancomycin resistant bacteria.
priorityDate 2004-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16154789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 33.